Search

State

Industry

Company

LABORATORY ANALYTICAL INSTRUMENTS

CONFIDENTIAL [*] = CERTAIN INFORMATION

Illumina, Inc.

CONFIDENTIAL [*] = CERTAIN INFORMATION IN THIS HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. COLLABORATION AGREEMENT This COLLABORATION AGREEMENT (this "Agreement") is made effective as of the 17th day of December, 2004 (the "Effective Date") by and among ILLUMINA, INC., a Delaware corporation having its

PHARMACEUTICAL PREPARATIONS

REGN-Ex_10.1-03/31/2015-10Q

Regeneron Pharmaceuticals, Inc.

AMENDED AND RESTATED COLLABORATION AGREEMENT BY AND BETWEEN SANOFI AND REGENERON REGN-Ex_10.1-03/31/2015-10Q Confidential Treatment has been requested for the redacted portions of this agreement. The redactions are indicated with four asterisks [****]. A complete version of this agreement has been filed separately with the Securities and Exchange Commission. AMENDED AND RESTATED COLLABORATION AGRE

PHARMACEUTICAL PREPARATIONS

Collaboration Agreement

Ambit Biosciences Corp

COLLABORATION AGREEMENT Collaboration Agreement ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and Rule 406 of the Securities Act of 1933, as amended. COLLABORATION AGREEMENT This Collaboration Agreement (the “ Agreement ”) is entered into as of September 14, 2010 (the “ Effective Date ”) by a

PHARMACEUTICAL PREPARATIONS

Collaboration Agreement

Amarin Corp Plc\Uk

ex4_78.htm Certain portions of this have been omitted pursuant to a request for “Confidential Treatment” under Rule 24b-2 of the Securities and Exchange Commission. Such portions have been redacted and bracketed in the request and appear as [*] in the text of this Exhibit. The omitted confidential information has been filed with the Securities and Exchange Commission. COLLABORATION AGREEMENT Betw

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Collaboration Agreement

Acorda Therapeutics Inc

Certain portions of this have been omitted pursuant to a request for confidentiality. Such omitted portions, which are marked with brackets [ ] and an asterisk*, have been separately filed with the Commission. COLLABORATION AGREEMENT by and between TEVA PHARMACEUTICAL INDUSTRIES LTD. and ACORDA THERAPEUTICS, INC. COLLABORATION AGREEMENT THIS COLLABORATION AGREEMENT (this “ Agreement ”) is made as

MEASURING & CONTROLLING DEVICES, NEC

AMENDED AND PARTIALLY RESTATED COLLABORATION

Aclara Biosciences Inc

AMENDED AND PARTIALLY RESTATED COLLABORATION AGMT. AMENDED AND PARTIALLY RESTATED COLLABORATION AGREEMENT BETWEEN ACLARA BIOSCIENCES, INC. AND PE CORPORATION (NY) Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information Subject to the confidentiality request. Omissions are designated as [*]. A complete version of this has been filed sepa

PHARMACEUTICAL PREPARATIONS

COLLABORATION AGREEMENT

Adolor Corp

COLLABORATION AGREEMENT Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as **. A complete version of this has been filed separately with the Securities and Exchange Commission. COLLABORATION AGREEMENT dated as of April 14, 2002 by and between ADOLOR CORPORATION and

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

Collaboration Agreement

Aradigm Corp

exv10w5 [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. COLLABORATION AGREEMENT This Collaboration Agreement (the “ Agreement ”) is entered into and made effective as of August 31, 2007 (the “ Effectiv

PHARMACEUTICAL PREPARATIONS

LEAD GENERATION COLLABORATION AGREEMENT

Array Biopharma Inc

LEAD GENERATION COLLABORATION AGREEMENT LEAD GENERATION COLLABORATION AGREEMENT This LEAD GENERATION COLLABORATION AGREEMENT (the "Agreement"), effective as of July 18, 2001 (the "Effective Date"), is made by and between Array BioPharma Inc., a Delaware corporation having its principal offices located at 1885 33rd Street, Boulder, CO 80301 ("Array"), and Takeda Chemical Industries, Ltd., a Japanes

PHARMACEUTICAL PREPARATIONS

DRUG DISCOVERY COLLABORATION AGREEMENT

Array Biopharma Inc

DRUG DISCOVERY COLLABORATION AGREEMENT DRUG DISCOVERY COLLABORATION AGREEMENT THIS DRUG DISCOVERY COLLABORATION AGREEMENT ("Agreement"), effective as of August 7, 2001 ("Effective Date"), is made by and between ICOS Corporation, a Delaware corporation having its principle offices located at 22021 20th Avenue S.E., Bothell, WA 98021, (hereinafter "ICOS"), and ARRAY BIOPHARMA CORPORATION, a Delaware